Decision Historical Financial Ratios

DECN Stock  USD 0.0001  0.00  0.00%   
Decision Diagnostics is recently reporting on over 79 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 182 or Book Value Per Share of 0.002 will help investors to properly organize and evaluate Decision Diagnostics financial condition quickly.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.

About Decision Financial Ratios Analysis

Decision DiagnosticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Decision Diagnostics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Decision financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Decision Diagnostics history.

Decision Diagnostics Financial Ratios Chart

At this time, Decision Diagnostics' Debt To Equity is very stable compared to the past year.
Add Fundamental
Price To Sales RatioPtb Ratio
Days Sales OutstandingBook Value Per Share
Free Cash Flow YieldInvested Capital
Operating Cash Flow Per ShareAverage Payables
Stock Based Compensation To RevenueCapex To Depreciation
Pb RatioEv To Sales
Free Cash Flow Per ShareRoic
Inventory TurnoverNet Income Per Share
Days Of Inventory On HandPayables Turnover
Sales General And Administrative To RevenueAverage Inventory
Research And Ddevelopement To RevenueCapex To Revenue
Cash Per SharePocfratio
Interest CoveragePayout Ratio
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingNet Current Asset Value
Income QualityRoe
Tangible Asset ValueEv To Operating Cash Flow
Pe RatioReturn On Tangible Assets
Ev To Free Cash FlowIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Dividend YieldEarnings Yield
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Cash Conversion Cycle

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Decision Diagnostics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Decision Diagnostics sales, a figure that is much harder to manipulate than other Decision Diagnostics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Price To Book Ratio

A ratio used to compare a firm's market value to its book value, calculated by dividing the current closing price of the stock by the latest quarter's book value per share.
Most ratios from Decision Diagnostics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Decision Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.At this time, Decision Diagnostics' Debt To Equity is very stable compared to the past year.
 2019 2020 2023 2024 (projected)
PTB Ratio24.899.928.939.38
Price To Sales Ratio0.922.422.792.65

Decision Diagnostics fundamentals Correlations

-0.040.2-0.11-0.14-0.110.140.17-0.041.0-0.11-0.680.180.110.07-0.210.090.98-0.1-0.23-0.65-0.17-0.320.170.960.53
-0.040.010.2-0.270.220.45-0.061.0-0.010.220.020.09-0.21-0.240.08-0.4-0.010.21-0.230.440.05-0.250.380.06-0.21
0.20.01-0.52-0.56-0.510.38-0.250.010.23-0.510.28-0.640.510.68-0.62-0.050.12-0.51-0.170.160.3-0.15-0.060.180.44
-0.110.2-0.520.541.0-0.470.10.2-0.11.0-0.440.83-1.0-0.160.95-0.56-0.161.00.05-0.09-0.1-0.010.52-0.22-0.46
-0.14-0.27-0.560.540.53-0.74-0.02-0.27-0.150.53-0.330.7-0.54-0.340.64-0.49-0.130.530.47-0.050.030.44-0.2-0.2-0.69
-0.110.22-0.511.00.53-0.460.10.22-0.11.0-0.440.82-1.0-0.160.94-0.56-0.161.00.05-0.08-0.1-0.010.53-0.22-0.46
0.140.450.38-0.47-0.74-0.460.290.450.16-0.460.24-0.560.470.16-0.570.260.15-0.46-0.350.13-0.2-0.330.130.240.46
0.17-0.06-0.250.1-0.020.10.29-0.060.150.1-0.220.19-0.10.030.130.20.20.10.1-0.42-0.80.08-0.030.170.25
-0.041.00.010.2-0.270.220.45-0.06-0.010.220.020.09-0.21-0.240.08-0.4-0.010.21-0.230.440.05-0.250.380.06-0.21
1.0-0.010.23-0.1-0.15-0.10.160.15-0.01-0.1-0.680.180.10.07-0.20.050.97-0.08-0.25-0.63-0.15-0.340.20.960.51
-0.110.22-0.511.00.531.0-0.460.10.22-0.1-0.440.82-1.0-0.160.94-0.56-0.161.00.05-0.08-0.1-0.010.53-0.22-0.46
-0.680.020.28-0.44-0.33-0.440.24-0.220.02-0.68-0.44-0.690.440.32-0.30.18-0.7-0.45-0.230.620.24-0.11-0.11-0.66-0.02
0.180.09-0.640.830.70.82-0.560.190.090.180.82-0.69-0.83-0.450.85-0.480.210.830.22-0.28-0.190.140.230.13-0.47
0.11-0.210.51-1.0-0.54-1.00.47-0.1-0.210.1-1.00.44-0.830.16-0.940.560.16-1.0-0.050.080.10.01-0.520.220.47
0.07-0.240.68-0.16-0.34-0.160.160.03-0.240.07-0.160.32-0.450.16-0.210.15-0.09-0.15-0.14-0.21-0.05-0.110.07-0.130.58
-0.210.08-0.620.950.640.94-0.570.130.08-0.20.94-0.30.85-0.94-0.21-0.51-0.230.940.05-0.05-0.140.010.43-0.31-0.53
0.09-0.4-0.05-0.56-0.49-0.560.260.2-0.40.05-0.560.18-0.480.560.15-0.510.13-0.550.0-0.48-0.290.03-0.30.090.72
0.98-0.010.12-0.16-0.13-0.160.150.2-0.010.97-0.16-0.70.210.16-0.09-0.230.13-0.15-0.18-0.62-0.2-0.260.080.990.47
-0.10.21-0.511.00.531.0-0.460.10.21-0.081.0-0.450.83-1.0-0.150.94-0.55-0.150.05-0.1-0.1-0.020.53-0.21-0.45
-0.23-0.23-0.170.050.470.05-0.350.1-0.23-0.250.05-0.230.22-0.05-0.140.050.0-0.180.05-0.16-0.10.99-0.8-0.22-0.26
-0.650.440.16-0.09-0.05-0.080.13-0.420.44-0.63-0.080.62-0.280.08-0.21-0.05-0.48-0.62-0.1-0.160.43-0.10.06-0.52-0.63
-0.170.050.3-0.10.03-0.1-0.2-0.80.05-0.15-0.10.24-0.190.1-0.05-0.14-0.29-0.2-0.1-0.10.43-0.080.03-0.15-0.26
-0.32-0.25-0.15-0.010.44-0.01-0.330.08-0.25-0.34-0.01-0.110.140.01-0.110.010.03-0.26-0.020.99-0.1-0.08-0.83-0.31-0.27
0.170.38-0.060.52-0.20.530.13-0.030.380.20.53-0.110.23-0.520.070.43-0.30.080.53-0.80.060.03-0.830.10.03
0.960.060.18-0.22-0.2-0.220.240.170.060.96-0.22-0.660.130.22-0.13-0.310.090.99-0.21-0.22-0.52-0.15-0.310.10.44
0.53-0.210.44-0.46-0.69-0.460.460.25-0.210.51-0.46-0.02-0.470.470.58-0.530.720.47-0.45-0.26-0.63-0.26-0.270.030.44
Click cells to compare fundamentals

Decision Diagnostics Account Relationship Matchups

Decision Diagnostics fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio3.461.120.922.422.792.65
Ptb Ratio3.782.1324.899.928.939.38
Days Sales Outstanding85.0155.04160.34174.05200.16181.67
Book Value Per Share0.01830.0093955.82E-40.0018140.0020860.001982
Operating Cash Flow Per Share(0.0165)(0.0106)(0.007413)(0.005271)(0.004744)(0.004981)
Pb Ratio3.782.1324.899.928.939.38
Ev To Sales3.961.642.043.584.123.92
Free Cash Flow Per Share(0.0178)(0.0113)(0.008187)(0.005271)(0.004744)(0.004981)
Roic(0.63)(0.69)(0.4)(0.62)(0.56)(0.59)
Inventory Turnover6.167.699.189.2210.610.07
Days Of Inventory On Hand59.2747.4439.7839.6135.6548.08
Payables Turnover2.421.871.220.871.00.95
Sales General And Administrative To Revenue1.190.940.731.171.051.36
Cash Per Share0.01160.002877.6E-40.001960.0022530.002141
Pocfratio(4.18)(1.89)(1.96)(3.42)(3.07)(2.92)
Days Payables Outstanding150.78194.97299.35419.79377.81223.38
Income Quality0.520.590.360.04740.04260.0448
Roe(1.74)(1.91)(35.76)(61.35)(70.55)(67.03)
Ev To Operating Cash Flow(4.78)(2.78)(4.36)(5.05)(4.54)(4.32)
Return On Tangible Assets(0.83)(0.88)(1.11)(9.38)(8.44)(8.02)
Ev To Free Cash Flow(4.45)(2.6)(3.95)(5.05)(5.81)(6.1)
Current Ratio0.830.580.270.330.30.28
Tangible Book Value Per Share9.99E-4(0.00435)(0.016)(0.00753)(0.00866)(0.008227)
Receivables Turnover4.292.352.282.12.412.29
Shareholders Equity Per Share0.01830.0093955.82E-40.0018140.0020860.001982
Debt To Equity1.181.335.746.055.445.72

Pair Trading with Decision Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Decision Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decision Diagnostics will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Decision Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Decision Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Decision Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Decision Diagnostics to buy it.
The correlation of Decision Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Decision Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Decision Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Decision Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Decision Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Decision Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Decision Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Decision Diagnostics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.02)
Revenue Per Share
0.006
Quarterly Revenue Growth
(0)
Return On Assets
(0.21)
Return On Equity
(81.61)
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.